Watson Biotech announced that the freeze-dried herpes zoster virus mRNA vaccine was developed by the company's subsidiary in collaboration with Fudan University and Blue Magpie Biology, and preparations for phase I clinical trials have been completed; the company held a phase I clinical trial launch meeting today to officially launch phase I clinical trials.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.